Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
- 20 September 1990
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 323 (12), 795-801
- https://doi.org/10.1056/nejm199009203231205
Abstract
Patients with head-and-neck cancers who are free of disease after local therapy remain at high risk for both recurrent and second primary tumors. Retinoids have proved efficacious in the treatment of premalignant oral lesions and are promising agents for the prevention of epithelial carcinogenesis. We prospectively studied 103 patients who were disease-free after primary treatment for squamous-cell cancers of the larynx, pharynx, or oral cavity. After completion of surgery or radiotherapy (or both), these patients were randomly assigned to receive either isotretinoin (13-cis-retinoic acid) (50 to 100 mg per square meter of body-surface area per day) or placebo, to be taken daily for 12 months. There were no significant differences between the two groups in the number of local, regional, or distant recurrences of the primary cancers. However, the isotretinoin group had significantly fewer second primary tumors. After a median follow-up of 32 months, only 2 patients (4 percent) in the isotretinoin group had second primary tumors, as compared with 12 (24 percent) in the placebo group (P = 0.005). Multiple second primary tumors occurred in four patients, all of whom were in the placebo group. Of the 14 second cancers, 13 (93 percent) occurred in the head and neck, esophagus, or lung. Daily treatment with high doses of isotretinoin is effective in preventing second primary tumors in patients who have been treated for squamous-cell carcinoma of the head and neck, although it does not prevent recurrences of the original tumor.Keywords
This publication has 32 references indexed in Scilit:
- Treatment-Related LeukemiaNew England Journal of Medicine, 1990
- Thinking About Cancer Causality and Chemoprevention2JNCI Journal of the National Cancer Institute, 1988
- Prevention of Skin Cancer in Xeroderma Pigmentosum with the Use of Oral IsotretinoinNew England Journal of Medicine, 1988
- 13-cis-Retinoic Acid in the Treatment of Oral LeukoplakiaNew England Journal of Medicine, 1986
- Inhibition of experimental oral carcinogenesis by topical beta caroteneCarcinogenesis: Integrative Cancer Research, 1986
- Chemotherapy in Head and Neck CancerNew England Journal of Medicine, 1983
- Hyperplasia, keratosis, dysplasia and carcinoma in situ of the vocal cords?a follow-up studyClinical Otolaryngology, 1982
- A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorshipBiometrika, 1970
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958